Drug Type Small molecule drug |
Synonyms L-373890 |
Target |
Action inhibitors |
Mechanism thrombin inhibitors(Factor IIa inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC22H30N6O4S |
InChIKeyHKBQMUGJGVGZIB-UHFFFAOYSA-N |
CAS Registry187162-33-0 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Thrombosis | Preclinical | United States | 01 Jun 1997 |





